Asia Pacific neurostimulation devices market is expected to grow at a high CAGR during the forecast period. The Asia Pacific neurostimulation devices market is driven by rising prevalence of chronic diseases in the region. In addition to this, increase in demand for MRI scans is anticipated to positively impact the growth of market during the forecast period. Furthermore, ongoing research related to the usage of neurostimulators in order to manage disorders like interstitial cystitis, asthma, among others is further expected to bolster the growth of market over the next few years.

With COVID-19 infections on the rise, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens, which is anticipated to fuel the market growth over the coming years.

The Asia Pacific neurostimulation devices market is segmented based on device type, application, company, and country. Based on device type, the market can be categorized into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Out of which, the spinal cord stimulators segment dominated the market until 2019 and is expected to maintain its dominance during the forecast period as well which can be attributed to high growth in number of product approvals. Additionally, increase in usage of spinal cord stimulators for treating neuropathic pain and spinal injuries, is further estimated to boost the segmental growth over the coming years.

Major players operating in the Asia Pacific neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc. and others. The key market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of Asia Pacific neurostimulation devices market from 2015 to 2018.
  • To estimate and forecast the market size of Asia Pacific neurostimulation devices market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast Asia Pacific neurostimulation devices market based on device type, application, company and country-wise distribution.
  • To identify dominant region or segment in the Asia Pacific neurostimulation devices market.
  • To identify drivers and challenges for Asia Pacific neurostimulation devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Asia Pacific neurostimulation devices market.
  • To conduct pricing analysis for Asia Pacific neurostimulation devices market.
  • To identify and analyze the profile of leading players operating in Asia Pacific neurostimulation devices market.
  • To identify key sustainable strategies adopted by market players in Asia Pacific neurostimulation devices market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the region. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers and presence of all major players across the region.

TechSci Research calculated the market size of Asia Pacific neurostimulation devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Neurostimulation devices manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to neurostimulation devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Asia Pacific neurostimulation devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Asia Pacific Neurostimulation Devices Market, By Device Type:
    • Spinal Cord Stimulators
    • Deep Brain Stimulators
    • Sacral Nerve Stimulators
    • Vagus Nerve Stimulators
    • Others
  • Asia Pacific Neurostimulation Devices Market, By Application:
    • Pain Management
    • Hearing Loss
    • Urinary Incontinence
    • Parkinson's Disease
    • Epilepsy
    • Others
  • Asia Pacific Neurostimulation Devices Market, By Country:
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Vietnam
    • Thailand
    • Indonesia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Asia Pacific neurostimulation devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Asia Pacific neurostimulation devices market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on ASIA PACIFIC Neurostimulation Devices Market

4.    Executive Summary

5.    Voice of Customer

6.    Asia Pacific Neurostimulation Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others)

6.2.2.     By Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others)

6.2.3.     By Company

6.2.4.     By Country

6.3.  Market Attractiveness Index

6.4.  Asia Pacific: Country Analysis

6.4.1.     India Neurostimulation Devices Market Outlook

6.4.1.1.         Market Size & Forecast

6.4.1.1.1.             By Value

6.4.1.2.         Market Share & Forecast

6.4.1.2.1.             By Device Type

6.4.1.2.2.             By Application

6.4.2.     China Neurostimulation Devices Market Outlook

6.4.2.1.         Market Size & Forecast

6.4.2.1.1.             By Value

6.4.2.2.         Market Share & Forecast

6.4.2.2.1.             By Device Type

6.4.2.2.2.             By Application

6.4.3.     Japan Neurostimulation Devices Market Outlook

6.4.3.1.         Market Size & Forecast

6.4.3.1.1.             By Value

6.4.3.2.         Market Share & Forecast

6.4.3.2.1.             By Device Type

6.4.3.2.2.             By Application

6.4.4.     South Korea Neurostimulation Devices Market Outlook

6.4.4.1.         Market Size & Forecast

6.4.4.1.1.             By Value

6.4.4.2.         Market Share & Forecast

6.4.4.2.1.             By Device Type

6.4.4.2.2.             By Application

6.4.5.     Australia Neurostimulation Devices Market Outlook

6.4.5.1.         Market Size & Forecast

6.4.5.1.1.             By Value

6.4.5.2.         Market Share & Forecast

6.4.5.2.1.             By Device Type

6.4.5.2.2.             By Application

6.4.6.     Singapore Neurostimulation Devices Market Outlook

6.4.6.1.         Market Size & Forecast

6.4.6.1.1.             By Value

6.4.6.2.         Market Share & Forecast

6.4.6.2.1.             By Device Type

6.4.6.2.2.             By Application

6.4.7.     Malaysia Neurostimulation Devices Market Outlook

6.4.7.1.         Market Size & Forecast

6.4.7.1.1.             By Value

6.4.7.2.         Market Share & Forecast

6.4.7.2.1.             By Device Type

6.4.7.2.2.             By Application

6.4.8.     Vietnam Neurostimulation Devices Market Outlook

6.4.8.1.         Market Size & Forecast

6.4.8.1.1.             By Value

6.4.8.2.         Market Share & Forecast

6.4.8.2.1.             By Device Type

6.4.8.2.2.             By Application

6.4.9.     Thailand Neurostimulation Devices Market Outlook

6.4.9.1.         Market Size & Forecast

6.4.9.1.1.             By Value

6.4.9.2.         Market Share & Forecast

6.4.9.2.1.             By Device Type

6.4.9.2.2.             By Application

6.4.10.  Indonesia Neurostimulation Devices Market Outlook

6.4.10.1.      Market Size & Forecast

6.4.10.1.1.           By Value

6.4.10.2.      Market Share & Forecast

6.4.10.2.1.           By Device Type

6.4.10.2.2.           By Application

7.    Market Dynamics

7.1.  Drivers

7.2.  Challenges

8.    Market Trends & Developments

9.    Competitive Landscape

9.1.  Abbott Laboratories

9.2.  Aleva neurotherapeutics SA

9.3.  Boston scientific corporation

9.4.  ElectroCore Inc.

9.5.  EndoStim Inc.

9.6.  Medtronic plc

9.7.  Nevro Corporation

9.8.  Neuronetics Inc

9.9.  NeuroSigma, Inc.

9.10.              Synapse Biomedical Inc

10.  Strategic Recommendations

11. About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]